Newer psychotropic medication use in nursing home residents

Journal of the American Geriatrics Society

Volumn 46, Issue 2, 1998, Pages 202-207

  Lasser, Robert A ^a   Sunderland, Trey ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZATROPINE; CARBAMAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DIPHENHYDRAMINE; FLUPHENAZINE; HALOPERIDOL; HYDROXYZINE; LITHIUM CARBONATE; NEFAZODONE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TIOTIXENE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; VALPROIC ACID; VENLAFAXINE;

AGED; ALZHEIMER DISEASE; ANXIETY NEUROSIS; ARTICLE; CLINICAL PRACTICE; DEPRESSION; DRUG EFFICACY; DRUG INDICATION; DRUG LEGISLATION; DRUG MISUSE; DRUG USE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; NURSING HOME; PRACTICE GUIDELINE; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0031952861     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb02540.x     Document Type: Article

References (72)

1. Seager CP. Chlorpromazine in treatment of elderly women. Br J Med 1955;1:882-885.
2. Pollack B. Addition of chlorpromazine to treatment program for emotional and behavioral disorders in aging. Geriatrics 1956;11:253-259.
3. Martin KE, Overley HG, Krone RE. Pipradol: Combined therapy for geriatric and agitated patients. Int Rec Med 1957;170:33-36.
4. Abse DW, Dahlstrom WG. The value of chemotherapy in senile mental disturbances. JAMA 1960;174:90-96.
5. Fracchia J, Sheppard C, Merlis S. Combination medications in psychiatric treatment: Patterns in a group of elderly hospital patients. J Am Geriatr Soc 1971;19:301-307.
6. Borson S, Liptzin B, Nininger J et al. Psychiatry and the nursing home. Am J Psychiatry 1987;144:1412-1418.
7. Burns BJ, Larson DB, Goldstrom ID et al. Mental disorder among nursing home patients: Preliminary findings from the national nursing home survey pretest. Int J Geriatr Psychiatry 1988;3:27-35.
8. Rovner BW. Depression and increased risk of mortality in the nursing home patient. Am J Med 1993;94(suppl 5a):19S-22S.
9. Snowdon J. Mental health in nursing homes. Drugs Aging 1993;3:122-130.
10. Reynolds MD. Institutional prescribing for the elderly. J Am Geriatr Soc 1984;32:640-645.
11. Burns BJ, Kamerow DB. Psychotropic drug prescriptions for nursing home residents. J Fam Pract 1988;26:155-160.
12. Beardsley RS, Larson DB, Burns BJ et al. Prescribing psychotropics in elderly nursing home patients. J Am Geriatr Soc 1989;37:327-330.
13. Cooper JW, Francisco GE. Psychotropic usage in long-term care facility geriatric patients. Hosp Formul 1981;16:407-419.
14. Ingman SR, Lawson IR, Pierpaoli PG et al. A survey of the prescribing and administration of drugs in a long-term care institution for the elderly. J Am Geriatr Soc 1975;23:309-316.
15. Kalchthler T, Coccaro E, Lichtiger S. Incidence of polypharmacy in a longterm care facility. J Am Geriatr Soc 1977;25:308-313.
16. Beers M, Avorn J, Soumerai SB et al. Psychoactive medication use in intermediate care facility residents. JAMA 1988;260:3016-3020.
17. Buck JA. Psychotropic drug practice in nursing homes. J Am Geriatr Soc 1988;36:409-418.
18. Avorn J, Dreyer P, Connelly K et al. Use of psychoactive medication and the quality of care in rest homes. N Engl J Med 1989;320:227-232.
19. Sternberg J, Spector WD, Drugovich ML et al. Use of psychoactive drugs in nursing homes: Prevalence and residents' characteristics. J Geriatr Drug Ther 1990;4:47-60.
20. Slater EJ, Glazer W. Use of OBRA-87 guidelines for prescribing neuroleptics in a VA nursing home. Psychiatr Serv 1995;46:119-121.
21. Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995;123:195-204.
22. Thapa PB, Gideon P, Fought RL et al. Psychotropic drugs and risk of recurrent falls in ambulatory nursing home resident. Am J Epidemiol 1995;142:202-211.
23. Avorn J, Soumerai SB, Everitt DE et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992;327:168-173.
24. Segal JL, Thompson JF, Floyd RA. Drug utilization and prescribing patterns in a skilled nursing facility: The need for a rational approach to therapeutics. J Am Geriatr Soc 1979;28:117-122.
25. Foerst H. Drug-prescribing patterns in skilled nursing facilities. Am J Nursing 1979;79:2002-2003.
26. Mendez MF, Martin RJ, Smyth KA et al. Psychiatric symptoms associated with Alzheimer's disease. J Neuropsychiatry 1990;2:28-33.
27. Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc 1990;38:542-552.
28. Svarstad BL, Mount JK. Nursing home resources and tranquilizer use among the institutionalized elderly. J Am Geriatr Soc 1991;39:869-875.
29. Rovner BW, German PS, Brant LJ et al. Depression and mortality in nursing homes. JAMA 1991;265:993-996.
30. Smith D. New rules for prescribing psychotropics in nursing homes. Geriatrics 1990;45:44-56.
31. Beers MH, Ouslander JG, Fingold SF et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992;117:684-689.
32. Everitt DE, Avorn J. Drug prescribing for the elderly. Arch Intern Med 1986;146:2393-2396.
33. Salzman C. Key concepts in geriatric psychopharmacology: Altered pharmacokinetics and polypharmacy. Psychiatr Clin North Am 1982;5:181-190.
34. Thompson TL, Moran MG, Nies AS. Psychotropic drug use in the elderly: Part I. N Engl J Med 1983;308:134-138.
35. Gerety MB, Cornell JE, Plichta DT et al. Adverse events related to drugs and drug withdrawal in nursing home residents. J Am Geriatr Soc 1993;41:1326-1332.
36. Cooper JW. Probable adverse drug reactions in a rural geriatric nursing home population: A four-year study. J Am Geriatr Soc 1996;44:194-197.
37. Ray WA, Federspiel CF, Schaffner W. A study of antipsychotic drug use in nursing homes: Epidemiologic evidence suggesting misuse. Am J Public Health 1980;70:485-491.
38. Barnes R, Veith R, Okimoto J et al. Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. Am J Psychiatry 1982;139:1170-1174.
39. Helms PM. Efficacy of antipsychotics in the treatment of the behavioral complications of dementia. J Am Geriatr Soc 1985;33:206-209.
40. Salzman C. Treatment of the elderly agitated patient. J Clin Psychiatry 1987;48(suppl):19-22.
41. Sunderland T, Silver M. Neuroleptics in the treatment of dementia. Int J Geriatr Psychiatry 1988;3:79-88.
42. Schneider LS, Pollock VE, Lyness SA. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990;38:553-563.
43. Ray WA, Taylor JA, Meador KG et al. Reducing antipsychotic drug use in nursing homes. Arch Intern Med 1993;153:713-721.
44. Katz IR, Simpson GM, Curlik SM et al. Pharmacologic treatment of major depression for elderly patients in residential care settings. J Clin Psychiatry 1990;51(suppl):41-47.
45. Parmelee PA, Katz IR, Lawton MP. Incidence of depression in long-term care settings. J Gerontol 1992;47:M189-196.
46. Katz, IR. Drug treatment of depression in the frail elderly: Discussion on the NIH consensus development conference on the diagnosis and treatment of depression in late life. Psychopharmacol Bull 1993;29:101-108.
47. Brodarty H, Harris L, Peters K et al. Prognosis of depression in the elderly: A comparison with younger patients. Br J Psychiatry 1993;163:589-596.
48. Alexopoulos GS, Meyers BS, Young RC et al. Recovery in geriatric depression. Arch Gen Psychiatry 1996;53:305-312.
49. Heston LL, Garrard J, Makris L et al. Inadequate treatment of depressed nursing home elderly. J Am Geriatr Soc 1992;40:1117-1122.
50. Baldessarini RJ. Drugs and the treatment of psychiatric disorders, psychosis and anxiety. In: Molinoff P, Ruddon R, eds. Goodman and Oilman's The Pharmacologic Basis of Therapeutics, 9th Ed. New York: McGraw Hill, 1996, pp 399-430.
51. Baldessarini RJ. Drugs and the treatment of psychiatric disorders, depression and mania. In: Molinoff P, Ruddon R, eds. Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 9th Ed. New York: McGraw Hill, 1996, pp 431-459.
52. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC: American Psychiatric Association, 1994.
53. Richelson E. Antimuscarimc and other receptor-blocking properties of antidepressants. Mayo Clin Proc 1983;58:40-46.
54. Gerrard J, Chen V, Dowd B. The impact of the 1987 Federal regulations on the use of psychotropic drugs in Minnesota nursing homes. Am J Public Health 1995;85:771-776.
55. Board of Directors of the AAGP. Position statement: Psychotherapeutic medications in the nursing home. J Am Geriatr Soc 1992;40:946-949.
56. Philpot M, Puranik A. Psychotropic drugs, aging, and community care. Drugs Aging, 1994;5:235-241.
57. Liston Jr EH. Diagnostic delay in presenile dementia. J Clin Psychiatry 1987;39:599-603.
58. Woerner MG, Alvir JM, Kane JM et al. Neuroleptic treatment of elderly patients. Psychopharmacol Bull 1995;31:333-337.
59. Monane M, Glynn RJ, Avorn J. The impact of sedative-hypnotic use on eep symptoms in elderly nursing home residents. Clin Pharmacol Ther 1996;59:83-92.
60. Robinson RG, Price TR. Post-stroke depressive disorders: A follow-up study of 103 patients. Stroke 1982;13:635-641.
61. Tannock C, Katona C. Minor depression in the aged: Concepts, prevalence and optimal management. Drugs Aging 1995;6:278-292.
62. Kamath M, Finkel SI, Moran MB. A retrospective chart review of antidepressant use, effectiveness, and adverse effects in adults age 70 and older. Am J Geriatr Psychiatry 1996;4:167-172.
63. Wijeratne C, Webster P. Risperidone and bullous pemphigoid . Am J Psychiatry (letter) 1996;153:735.
64. Semla TP, Palla K, Poddig B et al. Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. J Am Geriatr Soc 1994;42:648-652.
65. Zisselman MH, Rovner BW, Shmuely Y. Benzodiazepine use in the elderly prior to psychiatric hospitalization. Psychosomatics 1996;37:38-42.
66. Avorn J, Monane M, Everitt DE et al. Clinical assessment of extrapyramidal signs in nursing home patients. Arch Intern Med 1994;154:1113-1117.
67. Lantz MS, Louis A, Lowenstein G et al. A longitudinal study of psychotropic prescriptions in a teaching nursing home. Am J Psychiatry 1990;147:1637-1639.
68. Ray WA, Blazer DG, Schaffner W et al. Reducing antipsychotic drug prescribing for nursing home patients: A controlled trial of the effect of an educational visit. Am J Public Health 1987;77:1448-1450.
69. Rovner BW, Steele CD, Shmuely Yet al. A randomized trial of dementia care in nursing homes. J Am Geriatr Soc 1996;44:7-13.
70. Billig N, Cohen-Mansfield J, Lipson S. Pharmacologic treatment of agitation in a nursing home. J Am Geriatr Soc 1991;39:1002-1005.
71. Phan TT, Reifler BV. Psychiatric disorders among nursing home residents. Clin Geriatr Med 1995;4:601-611.
72. Jacobson DH, Winograd CH. Psychoactive medications in the long-term care setting: Differing perspectives among physicians, nursing staff, and patients. J Geriatr Psychiatr Neurol 1994;7:176-183.